Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stakeholders To Have Say On Future Medicines Verification System In UK

EU Offers Flexibilities On GB Exports To Selected Countries

Executive Summary

The UK government says it will begin a consultation on a future falsified medicines scheme for Great Britain within a year after the passage of new legislation on medicines and medical devices. Moves are also under way to ensure the smooth supply of medicines from GB to Cyprus, Ireland, Malta and Northern Ireland.

You may also be interested in...



Navigating The UK's Post-Brexit Regulatory Complexities

The UK regulator explains the new requirements for batch testing and release in Great Britain and Northern Ireland, what's involved in importing clinical trial drugs to Northern Ireland, and what factors determine the location of the Qualified Person.

How To Set Up A Medicines Traceability System

With falsified and substandard medicines still posing a major threat to populations around the world, two international organizations have set out guidance on the best way to design and implement tracing systems that work together at global level using common standards and technology.

UK Reveals Plan To Improve Access To Safe New Medicines

The three-year Delivery Plan just unveiled by the UK medicines agency is part of its aim to create a “new era” in drug regulation.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS143632

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel